Table 2. Clinical profile of study participants (non-TNBC females) from London Health Science Centre.
| Characteristics | Number (range) | Fibulin-3 (ng/ml) |
|---|---|---|
| Normal Subjects | ||
| Age (years) | Mean 25.8 (22–55) | 14.45 ± 4.4 |
|
ER/PR Positive (HER2-negative) patients Age (years) |
Mean 69.4 (51–92) | 16.99 ± 5.8 |
| Tumor size (mm) | Mean 17.0 (6–45) | |
| Surgery performed for tumor removal | 28/29 | |
| No surgery (primary tumor present) | 1/29 | |
| hemotherapy | 4/29 | |
| Radiation therapy | 19/29 | |
| Tumor size | ||
| T1 | 21 | |
| T2 | 8 | |
| T3 | 0 | |
| T4 | 0 | |
| Node status | ||
| N0 | 22 | |
| N1 | 2 | |
| N2 | 0 | |
| N3 | 0 | |
| Nx | 5 | |
| Metastasis | 0/29 |